Zhejiang Tailin Bioengineering Co

Zhejiang Tailin Bioengineering Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zhejiang Tailin Bioengineering Co (300813.SZ) as of Oct 31, 2026 is 844,801.00 CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 25.00 M CNY — a change of -96.62% (lower).

EBITDA

844,801.00CNY

YoY

-96.62%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zhejiang Tailin Bioengineering Co is 2025 844,801.00 CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zhejiang Tailin Bioengineering Co was 2024 25.00 M CNY. It decreases by -96.62% lower compared to the previous year.

The Zhejiang Tailin Bioengineering Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
56.04 M CNY
Jan 1, 2019
43.93 M CNY
Jan 1, 2020
58.19 M CNY
Jan 1, 2021
74.77 M CNY
Jan 1, 2022
85.71 M CNY
Jan 1, 2023
27.95 M CNY
Jan 1, 2024
25.00 M CNY
Jan 1, 2025
844,801.00 CNY
The Zhejiang Tailin Bioengineering Co EBITDA history
YEAREBITDAYoY
844,801.00CNY-96.62%
25.00 MCNY-10.56%
27.95 MCNY-67.39%
85.71 MCNY+14.64%
74.77 MCNY+28.49%
58.19 MCNY+32.45%
43.93 MCNY-21.60%
56.04 MCNY+12.73%
49.71 MCNY+69.70%
29.29 MCNY+133.28%
12.56 MCNY+79.14%
7.01 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Tailin Bioengineering Co Stock analysis

What does Zhejiang Tailin Bioengineering Co do? Zhejiang Tailin Bioengineering Co., Ltd. generates revenue through the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products and organic substance analysis instruments. The company's main products consist of consumables, instruments, and equipment used in sterile drug production and quality control, targeting pharmaceutical manufacturers and laboratories. These products serve applications in medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection sectors. The firm distributes its products domestically and internationally, with a focus on the Chinese market and overseas markets. The company's revenue streams are derived from the sale of microbial detection and control technology system products, organic substance analysis instruments, and related consumables. Pharmaceutical manufacturers and laboratory facilities are the primary customers purchasing these products for quality assurance and production processes. The application segments include medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection, which are served through both domestic and international distribution channels. Zhejiang Tailin Bioengineering's business model centers on selling specialized pharmaceutical equipment to industries requiring sterile drug production and quality control. The firm's products are utilized across multiple sectors such as medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. Sales occur within the domestic market and overseas markets, with a strong emphasis on the Chinese market and international expansion. Zhejiang Tailin Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Tailin Bioengineering Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zhejiang Tailin Bioengineering Co is 844,801.00 CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zhejiang Tailin Bioengineering Co changed from 25.00 M CNY to 844,801.00 CNY, representing a -96.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Zhejiang Tailin Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Zhejiang Tailin Bioengineering Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Zhejiang Tailin Bioengineering Co

All Key Metrics — Zhejiang Tailin Bioengineering Co